Cargando…
Special considerations for therapeutic choice of non–vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation
Nonvalvular atrial fibrillation (AF) is a risk factor for stroke in elderly patients. Although warfarin has been used to prevent AF‐associated stroke for more than 50 years, non–vitamin K antagonist oral anticoagulants (NOACs) including dabigatran, rivaroxaban, apixaban, and edoxaban recently have b...
Autores principales: | Okumura, Ken, Hori, Masatsugu, Tanahashi, Norio, John Camm, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347841/ https://www.ncbi.nlm.nih.gov/pubmed/27716968 http://dx.doi.org/10.1002/clc.22596 |
Ejemplares similares
-
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
por: Deitelzweig, Steven, et al.
Publicado: (2021) -
Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
por: Lee, Hsin‐Fu, et al.
Publicado: (2019) -
Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
por: Sen, Souvik, et al.
Publicado: (2014) -
Concomitant diabetes with atrial fibrillation and anticoagulation management considerations
por: Kreutz, Reinhold, et al.
Publicado: (2020) -
Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
por: Ment, Jerome
Publicado: (2015)